Yan Leyfman?linkedIn
Oct 19, 2025, 11:19
Yan Leyfman: Insightful Strategies Advancing the Safety and Precision of Myeloma Care
Yan Leyfman, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Exceptional presentation by global multiple myeloma cell therapy leader Dr. Adriana Rossi (Icahn School of Medicine at Mount Sinai) on managing T-cell–directed toxicities at the 2025 Lymphoma, Leukemia & Myeloma Congress!
Insightful strategies advancing the safety and precision of myeloma care.”
Stay updated with Hemostasis Today.
-
Oct 25, 2026, 19:23Özlem Turan: Advancing Care for Women and Girls With Bleeding Disorders at the European Parliament
-
Oct 25, 2026, 18:36James P. Crowley: Gene Inactivation and Targeted Gene Repair as Two Approaches to CRISPR Gene Editing
-
Oct 25, 2026, 17:43Jan Sloves: Femoral Vein Aneurysm and Chronic Venous Obstruction
-
Oct 25, 2026, 17:31Kasimu Hussaini: Blood Component Therapy From Whole Blood to Targeted Treatment
-
Oct 25, 2026, 17:23Zahra Safarzadeh: When Low Factor VII Activity and Reduced VWF Antigen Coexist
-
Oct 25, 2026, 17:17Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember
-
Oct 25, 2026, 17:04Tehila Alter: Tracking Hematopoietic Cell Engraftment in Bone Marrow Using CEST MRI
-
Oct 25, 2026, 16:45Shauna Riley։ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions